ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
191 hedge funds and large institutions have $2.56B invested in Array Biopharma Inc in 2017 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 75 increasing their positions, 57 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more capital invested
Capital invested by funds: $2.41B → $2.56B (+$154M)
4% more funds holding
Funds holding: 184 → 191 (+7)
Holders
191
Holding in Top 10
7
Calls
$44M
Puts
$22.5M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$24.8M | |
| 3 | +$23.7M | |
| 4 |
BlackRock
New York
|
+$21.9M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$20.9M |
Top Sellers
| 1 | -$84M | |
| 2 | -$42.2M | |
| 3 | -$18.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18.6M |
| 5 |
Two Sigma Investments
New York
|
-$14.6M |